Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Chemical Industry News Pidilite Industries appoints Sudhanshu Vats as deputy managing director Pidilite Industries, an Indian adhesives manufacturing company that owns the Fevicol brand, said that Sudhanshu Vats will join… byPallavi MadhirajuJuly 18, 2021